Snowball logo
logo
4527_logo

Rohto Pharmaceutical Co.Ltd.

4527 TSE
¥2,784.50-¥65.00  (2.28%)
Estimate
P/E
19.2
EPS
145.39
Beta
-0.458
Growth
Revenue, YoY
11.79%
Net income, YoY
-9.5%
Forecast
P/E (FWD)
18.8
EPS (FWD)
147.846
Dividends
Dividend yield
1.8%
Annual payout
¥50.00
Next ex. div date
September 30, 26
Payout
27.05%
Div.growth, 5y
25.83%
Dividend growth streak
5 y
Div.rating
About the company
Ticker
4527
ISIN
JP3982400008
Country
Japan
Sector (GICS)
Healthcare
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. The company was founded in 1899 and is headquartered in Osaka, Japan.

Frequently asked questions

What sector does Rohto Pharmaceutical Co.Ltd. (4527) operate in?

Rohto Pharmaceutical Co.Ltd. belongs to the Healthcare sector and operates in the Household & Personal Products industry.

What is Rohto Pharmaceutical Co.Ltd. (4527) current stock price?

As of the latest data, Rohto Pharmaceutical Co.Ltd. stock price is ¥2,785, with a previous close of ¥2,850. Rohto Pharmaceutical Co.Ltd. lost -¥65 in the last trading session, representing a -2.28% loss.

What is Rohto Pharmaceutical Co.Ltd. (4527) current market capitalization?

Rohto Pharmaceutical Co.Ltd. market cap is approximately 629.20 billion.

What is Rohto Pharmaceutical Co.Ltd. (4527) Earnings Per Share (EPS)?

The trailing EPS is ¥145, and the forward EPS is ¥148.

What is Rohto Pharmaceutical Co.Ltd. (4527) Price-to-Earnings (P/E) ratio?

Rohto Pharmaceutical Co.Ltd. current P/E ratio is 19.15, with a forward P/E of 18.83.

What is Rohto Pharmaceutical Co.Ltd. (4527) EBITDA?

Rohto Pharmaceutical Co.Ltd. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 18.16 billion.

Does Rohto Pharmaceutical Co.Ltd. (4527) pay dividends?

Yes. Rohto Pharmaceutical Co.Ltd. pays semiannual dividends with an annualized yield of 1.8% and an estimated annual payout of ¥50 per share.

When is the next ex-dividend date for Rohto Pharmaceutical Co.Ltd. (4527)?

The next ex-dividend date is scheduled for September 30, 2026.

How did Rohto Pharmaceutical Co.Ltd. (4527) perform in its most recent earnings report?

In the last report (June 30, 2026), Rohto Pharmaceutical Co.Ltd. posted an EPS surprise of 18.26% and a revenue surprise of 5.25%.

When is Rohto Pharmaceutical Co.Ltd. (4527) next earnings report?

Rohto Pharmaceutical Co.Ltd. is expected to release its next earnings report on September 30, 2026.

What is Rohto Pharmaceutical Co.Ltd. (4527) beta (volatility) score?

Rohto Pharmaceutical Co.Ltd. has a beta of -0.458, indicating lower volatility than the overall market.